Home›People›Randall Stanicky
Randall Stanicky

Randall Stanicky

Director at Cellphire. Also a chief financial officer at Click Therapeutics.

ExecutiveDirectorRoles at 2 startups
Updated Nov 9, 2026·Latest SEC filing Oct 1, 2026·Suggest an edit

About Randall Stanicky

Randall Stanicky is a director at Cellphire.

Form D filings also name Randall Stanicky as a chief financial officer at Click Therapeutics.

Randall Stanicky first appears on SEC filings in 2021.

Experience

This experience comes from Randall Stanicky's profile and from SEC filings. For roles taken from filings, the years are when the filings name Randall Stanicky in the role, so the role may have started earlier or lasted longer.

Mauna Kea Technologies Current
Board Member
2026 – Present
Cellphire, Inc. Current
Director
2025 – Present · Rockville, MD
The F Suite Current
Founding Member - Steering Committee Member 2025
2022 – Present
Click Therapeutics, Inc. Current
Chief Financial Officer
2021 – Present · New York, NY
Prescription software treatments for people with unmet medical needs.
Children's Tumor Foundation Current
Honorary Board Member
2014 – Present
RBC Capital Markets
Managing Director
2013 – 2021
TherapeuticsMD
Board Member
2013 – 2015
Canaccord Genuity Inc.
Managing Director
2011 – 2013
Goldman Sachs
Vice President
2001 – 2011
Citigroup Global Asset Management
Associate
1999 – 2001
Agrifoods International Cooperative Ltd
Manager, Real Estate Administration - Corporate Finance Department
1997 – 1999

Key Colleagues at Startups

The people Randall Stanicky works with at each company, as listed on that company's latest Form D.

Click Therapeutics, Inc. · Form D, Oct 1, 2026
DK
David Klein
Founder & CEO, director
CL
Cris De Luca
Director
AZ
Alex Zisson
Director
MF
Maria Forero
Director
DF
BR
DL
Cellphire, Inc. · Form D, Dec 11, 2025
PC
RJ
Rafael Jorda
Director
TD
Thomas Dubin
Director
MG
Michael Gaffney
Chief Executive Officer and director
DW
Derek Woods
Director
JP
James Peake
Director

Sources

  1. SECClick Therapeutics, Inc. Form D, filed Oct 1, 2026
  2. SECCellphire, Inc. Form D, filed Dec 11, 2025